Craft

AtriCure

Stock Price

$29.4

2024-10-29

Market Capitalization

$1.4 B

2024-10-29

Revenue

$534.5 M

FY, 2025

AtriCure Summary

Company Summary

Overview
AtriCure is a medical device company that provides atrial fibrillation solutions. Its products include Isolator Synergy Clamps, surgical treatment of atrial fibrillation, AtriClip System, an implanted left atrial appendage exclusion (LAAE) device utilized to reduce the risk of stroke.; LARIAT System, a solution for soft-tissue closure, etc.
Type
Public
Status
Active
Founded
2000
HQ
Mason, OH, US | view all locations
Website
https://www.atricure.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Michael H. Carrel

    Michael H. Carrel, President, Chief Executive Officer, and Director

  • Angela L. Wirick

    Angela L. Wirick, Chief Financial Officer

  • Justin Noznesky

    Justin Noznesky, Chief Marketing and Strategy Officer

  • Karl Dahlquist

    Karl Dahlquist, Chief Legal Officer

Operating MetricsView all

Facility Space, sq. ft.

178.5K
17.4%

FY, 2022

Products

6

FY, 2022

Facility Space Leased, sq. ft.

178.5K

FY, 2022

LocationsView all

4 locations detected

  • Mason, OH HQ

    United States

    7555 Innovation Way

  • Minnetonka, MN

    United States

    130 Cheshire Ln #250

  • Pleasanton, CA

    United States

    3875 Hopyard Rd # 160

  • Amsterdam, NH

    Netherlands

    De Entree 260

AtriCure Financials

Summary Financials

Revenue (Q1, 2026)
$141.2M
Gross profit (Q1, 2026)
$109.3M
Net income (Q1, 2026)
$108.0K
Cash (Q1, 2026)
$146.2M
EBIT (Q1, 2026)
$526.0K
Enterprise value
$1.3B

Footer menu